DyNAbind GmbH logo

DyNAbind GmbH

Accelerating Drug Discovery

8 employees · est. 2017 · Dresden, Germany

VS
Nuclera logo

Nuclera

Bring rapid protein access to your benchtop with eProtein Discovery

116 employees · est. 2013 · Cambridge, United Kingdom

Nuclera is the older company (2017 vs 2013); Nuclera is the larger of the two.

Side-by-Side Comparison

DyNAbind GmbH Nuclera
Founded
2017 2013 older
Headquarters
Dresden, Germany Cambridge, United Kingdom
Employees
8 116 larger
Industry
Biopharma, Biotechnology Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Seed Series C
Total Funding
Not tracked yet $207.83M
Funding Rounds
1 9
Services
Not tracked yet eProtein Discovery System, Antibody Screening Services, Protein Design and Expression, Membrane Protein Production
Target Customers
Not tracked yet Biotechnologists, Pharmaceutical Researchers, Drug Discovery Scientists, Structural Biologists, Academic Research Institutions
Taxonomy
Drug Discovery, DNA-Encoded Libraries, Small Molecule Discovery, Fragment-Based Discovery, Medicinal Chemistry, Pharmaceutical Research, Biotechnology Innovation, High-Throughput Screening, Protein Targets, Innovative Technology, Biotech Partnership, Academic Collaborations Protein Science, Multiplex Protein Screening, Cell-free Expression Systems, Digital Microfluidics, Protein Characterization, Drug Discovery, Membrane Proteins, Biotech Innovation, Research Acceleration, Protein Optimization, Lab Automation, Protein Synthesis, Biotech Startup, Scientific Research Tools, Rapid Protein Prototyping
Website
dynabind.com nuclera.com
DyNAbind GmbH logo

About DyNAbind GmbH

DyNAbind is a Germany-based startup that is revolutionizing drug discovery with its innovative DNA-Encoded Library platform. Founded in 2017, the company's slogan "Accelerating Drug Discovery" encapsulates its mission to provide fast, reliable, and high-quality medicinal chemistry starting points fo...

Nuclera logo

About Nuclera

Nuclera, founded in 2013 by PhD students at the University of Cambridge, has positioned itself as a transformative player in the biotechnology, life sciences, and pharmaceutical industries. With its headquarters in the United Kingdom and a burgeoning presence in Boston, MA, the company employs over...

We will tell you when either one moves

BounceWatch watches DyNAbind GmbH and Nuclera for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at DyNAbind GmbH and Nuclera — by email.

Frequently Asked Questions

DyNAbind GmbH — Accelerating Drug Discovery. Nuclera — Bring rapid protein access to your benchtop with eProtein Discovery. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DyNAbind GmbH has raised undisclosed funding while Nuclera has raised $207.83M.
DyNAbind GmbH and Nuclera operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DyNAbind GmbH with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DyNAbind GmbH on 11 Sep 2024, and Nuclera on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy